These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16735291)

  • 21. Twenty years of HIV surveillance in the Pacific--what do the data tell us and what do we still need to know?
    Sladden T
    Pac Health Dialog; 2005 Sep; 12(2):23-37. PubMed ID: 18181491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Projecting the demographic consequences of adult HIV prevalence trends: the Spectrum Projection Package.
    Stover J
    Sex Transm Infect; 2004 Aug; 80 Suppl 1(Suppl 1):i14-18. PubMed ID: 15249694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimating and projecting HIV prevalence and AIDS deaths in Tanzania using antenatal surveillance data.
    Somi GR; Matee MI; Swai RO; Lyamuya EF; Killewo J; Kwesigabo G; Tulli T; Kabalimu TK; Ng'ang'a L; Isingo R; Ndayongeje J
    BMC Public Health; 2006 May; 6():120. PubMed ID: 16672043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances and future directions in HIV surveillance in low- and middle-income countries.
    Diaz T; Garcia-Calleja JM; Ghys PD; Sabin K
    Curr Opin HIV AIDS; 2009 Jul; 4(4):253-9. PubMed ID: 19532061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Findings from the 2017 HIV estimation round & trend analysis of key indicators 2010-2017: Evidence for prioritising HIV/AIDS programme in India.
    Sahu D; Kumar P; Chandra N; Rajan S; Shukla DK; Venkatesh S; Nair S; Kumar A; Singh J; Reddy S; Godbole S; Elangovan A; Saha MK; Rai S; Lakshmi PVM; Gambhir T; Ammassari S; Joshi D; Das A; Bakshi P; Chakraborty S; Palkar A; Singh SK; Reddy DCS; Kant S; Pandey A; Vardhana Rao MV
    Indian J Med Res; 2020 Jun; 151(6):562-570. PubMed ID: 32719229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using estimation and projection package and Spectrum for Jamaica's national HIV estimates and targets.
    Duncan J; Beckford Jarrett S; Harvey K
    Sex Transm Infect; 2010 Dec; 86 Suppl 2(Suppl_2):ii43-7. PubMed ID: 21106514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved estimates of India's HIV burden in 2006.
    Pandey A; Reddy DC; Ghys PD; Thomas M; Sahu D; Bhattacharya M; Maiti KD; Arnold F; Kant S; Khera A; Garg R
    Indian J Med Res; 2009 Jan; 129(1):50-8. PubMed ID: 19287057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV/AIDS' spread and impact on other health-related millennium development goals--secondary publication.
    Alban A; Andersen NB
    Dan Med Bull; 2007 May; 54(2):163-6. PubMed ID: 17521537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A stochastic infection rate model for estimating and projecting national HIV prevalence rates.
    Bao L; Raftery AE
    Sex Transm Infect; 2010 Dec; 86 Suppl 2(Suppl_2):ii93-9. PubMed ID: 21106521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Updates to the Spectrum/Estimations and Projections Package model for estimating trends and current values for key HIV indicators.
    Stover J; Brown T; Puckett R; Peerapatanapokin W
    AIDS; 2017 Apr; 31 Suppl 1():S5-S11. PubMed ID: 28296796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methods and procedures for estimating HIV/AIDS and its impact: the UNAIDS/WHO estimates for the end of 2001.
    Walker N; Stanecki KA; Brown T; Stover J; Lazzari S; Garcia-Calleja JM; Schwartländer B; Ghys PD
    AIDS; 2003 Oct; 17(15):2215-25. PubMed ID: 14523279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV infection does not disproportionately affect the poorer in sub-Saharan Africa.
    Mishra V; Assche SB; Greener R; Vaessen M; Hong R; Ghys PD; Boerma JT; Van Assche A; Khan S; Rutstein S
    AIDS; 2007 Nov; 21 Suppl 7():S17-28. PubMed ID: 18040161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tuberculosis deaths in countries with high HIV prevalence: what is their use as an indicator in tuberculosis programme monitoring and epidemiological surveillance?
    Maher D; Watt CJ; Williams BG; Raviglione M; Dye C
    Int J Tuberc Lung Dis; 2005 Feb; 9(2):123-7. PubMed ID: 15732729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
    Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
    Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV estimates at second subnational level from national population-based surveys.
    Larmarange J; Bendaud V
    AIDS; 2014 Nov; 28 Suppl 4(4):S469-76. PubMed ID: 25406750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comprehensive back-calculation framework for estimation and prediction of HIV/AIDS in India.
    Venkatesan P
    J Commun Dis; 2006 Mar; 38(1):40-56. PubMed ID: 17370689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antenatal clinic-based HIV prevalence in Zambia: declining trends but sharp local contrasts in young women.
    Sandøy IF; Kvåle G; Michelo C; Fylkesnes K
    Trop Med Int Health; 2006 Jun; 11(6):917-28. PubMed ID: 16772014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sexually transmitted disease and HIV prevalence and risk factors in concentrated and generalized HIV epidemic settings.
    NIMH Collaborative HIV/STD Prevention Trial Group
    AIDS; 2007 Apr; 21 Suppl 2():S81-90. PubMed ID: 17413267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. National estimate of HIV prevalence in the Netherlands: comparison and applicability of different estimation tools.
    van Veen MG; Presanis AM; Conti S; Xiridou M; Stengaard AR; Donoghoe MC; van Sighem AI; van der Sande MA; De Angelis D
    AIDS; 2011 Jan; 25(2):229-37. PubMed ID: 21150562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Theorizing "Big Events" as a potential risk environment for drug use, drug-related harm and HIV epidemic outbreaks.
    Friedman SR; Rossi D; Braine N
    Int J Drug Policy; 2009 May; 20(3):283-91. PubMed ID: 19101131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.